Publication | Open Access

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

ThrombosisVenous DiseaseVenous ThrombosisDabigatran EtexilateVenous Disease TreatmentPhase 2B/3HematologyPediatricsNon-inferiority TrialMedicineAnticoagulant